ArticleBreast cancer : basic and clinical research2024

Multicenter Prospective Study in HER2-Positive Early Breast Cancer for Detecting Minimal Residual Disease by Circulating Tumor DNA Analysis With Neoadjuvant Chemotherapy: HARMONY Study.

Momoko Tokura et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.